Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial

J. Bengtson, M. Adolphson, D. L. Brewer, D. Jacobs, J. L. Gard, L. Cahoon, M. Bloom, B. Kennelly, K. Porter, J. Kmonicek, F. M. Krainin, J. Shane, J. F. Marquis, S. A. Kearns, D. J. Moliterno, P. DeSantis, E. M. Ohman, C. Martz, D. L. Brown, M. BulleyS. Worley, J. Slovak, L. Hollywood, K. Knepper, K. Browne, M. Telatnik, M. Frey, T. Browning, W. French, S. Wang, N. S. Kleiman, L. Baysinger, A. Edwards, G. Barbeau, M. M. Lariviere, J. Hermiller, S. Diel, J. S. Wilson, A. Friedewald, A. N. Tenaglia, R. Bozeman, W. Roper, W. Grossman, K. Fletcher, R. Andersen, L. Hollywood, D. Spriggs, S. Wahl, J. D. Talley, M. Boyles, D. Almond, J. White, A. G. Adelman, V. Foulger, S. Webber, C. Kells, T. Fawcett, J. Butler, J. Scrivner, M. J. Miller, B. Owens, C. Corder, C. Clinton, J. Johnson, M. Myrna, K. Carr, J. Calarco, J. Glassman, A. Stein, D. Marsh, B. Penny, D. Small, D. Goodman, D. Walston, J. Butler, J. Scrivner, M. J. Koren, K. Teeter, M. Hudson

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science